$72.41+0.24 (+0.33%)
Ralliant Corporation engages in the design, development, manufacture, sale, and service of precision instruments and engineered products in the United States, China, and internationally.
Ralliant Corporation in the Technology sector is trading at $72.41 with a market capitalization of $7.7B. Wall Street consensus targets $68.70 (10 analysts), implying a -5.1% move over the next 12 months. The stock is currently near its 52-week high of $75.41, remaining 47.3% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $534.60M↓ | $554.50M↑ | $529.10M↑ | $503.30M↑ | $481.80M |
| Gross Profit | $272.30M↓ | $279.90M↑ | $268.60M↑ | $248.30M↑ | $243.40M |
| Operating Income | $68.10M↓ | $73.90M↑ | $52.00M↓ | $58.90M↓ | $73.80M |
| Net Income | $44.20M↑ | -$1.37B↓ | $39.90M↓ | $47.60M↓ | $63.90M |
Ralliant Corporation engages in the design, development, manufacture, sale, and service of precision instruments and engineered products in the United States, China, and internationally. It operates through two segments, Test and Measurement; and Sen...
Here is how Healthcare Services (HCSG) and Ralliant (RAL) have performed compared to their sector so far this year.
Ralliant stock reacts to recent performance metrics Ralliant (RAL) has drawn investor attention after recent trading, with the stock last closing at US$66.08 and showing double digit returns over the month and past 3 months. See our latest analysis for Ralliant. For context, the stock has shown strong short term momentum, with a 52.75% 3 month share price return and a 29.01% year to date share price return from the current level of US$66.08. Longer term total shareholder return figures are...
Ralliant Corporation (NYSE:RAL) was among the stocks Jim Cramer discussed on Mad Money, along with the recent sell-off in the market. Inquiring about the stock, a caller highlighted the company’s last reported “great” quarter and its buyback program. Cramer remarked: That is a good company. But you know what? It’s gone parabolic. The stock’s going […]
Here is how Healthcare Services (HCSG) and Ralliant (RAL) have performed compared to their sector so far this year.
ICF International points to big contract wins, a $3.4B backlog and strong liquidity, but higher pass-through costs and heavier M&A leverage add risks.